keyword
Keywords Antihypertensives treatment gu...

Antihypertensives treatment guideline review

https://read.qxmd.com/read/38000103/peanut-arachis-hypogaea-l-seeds-and-by-products-in-metabolic-syndrome-and-cardiovascular-disorders-a-systematic-review-of-clinical-studies
#21
REVIEW
Yandra Cervelim Nunes, Gian de Oliveira Santos, Nathália Mendes Machado, Alda M M B Otoboni, Lucas Fornari Laurindo, Anusha Bishayee, Carmela Fimognari, Anupam Bishayee, Sandra Maria Barbalho
BACKGROUND: Cardiovascular disease (CVDs) is the leading cause of death worldwide. The main risk factors are hypertension, diabetes, obesity, and increased serum lipids. The peanut (Arachis hypogaea L.), also known as the groundnut, goober, pindar, or monkey nut, belongs to the Fabaceae family and is the fourth most cultivated oilseed in the world. The seeds and skin of peanuts possess a rich phytochemical profile composed of antioxidants, such as phenolic acids, stilbenes, flavonoids, and phytosterols...
November 3, 2023: Phytomedicine
https://read.qxmd.com/read/37915282/etiology-risk-factors-and-management-of-hypertension-post-liver-transplantation
#22
REVIEW
Eline Braekman, Ruth De Bruyne, Kristof Vandekerckhove, Agnieszka Prytula
BACKGROUND: Cardiovascular events are one of the most important causes of morbidity and mortality in the long-term follow-up of liver transplant recipients. Hypertension is a significant cardiovascular risk factor that occurs frequently after pediatric liver transplantation. Chronic use of immunosuppressants - mainly calcineurin inhibitors - plays a major role in the development of post-transplant hypertension and circadian disturbances such as flattening of the nocturnal blood pressure dip...
November 1, 2023: Pediatric Transplantation
https://read.qxmd.com/read/37897111/hypertension-in-the-emergency-department-a-missed-opportunity-to-screen-for-primary-aldosteronism
#23
JOURNAL ARTICLE
Rachel D Graven, Ignatius Lee, Jing Ren, Jun Yang, Diana Egerton-Warburton
OBJECTIVES: Primary aldosteronism (PA) is a common but under-diagnosed secondary cause of hypertension. Emergency departments (EDs) often assess patients with severe hypertension or its sequelae, some of whom have underlying PA. We aimed to determine the proportion of patients presenting to the ED with hypertension who meet the Endocrine Society criteria for PA testing, and the proportion who were screened. METHODS: We performed a structured retrospective chart review of adults who presented to three EDs in an Australian tertiary health network between August 2019 and February 2020, with a coded presenting complaint of hypertension...
October 28, 2023: Academic Emergency Medicine
https://read.qxmd.com/read/37857042/treatment-of-acute-onset-hypertension-in-pregnancy-a-network-meta-analysis-of-randomized-controlled-trials-comparing-anti-hypertensives-and-route-of-administration
#24
REVIEW
Adithya D Bhat, Paige M Keasler, Lavanya Kolluru, Michael M Dombrowski, Arvind Palanisamy, Preet Mohinder Singh
BACKGROUND: Consensus on the relative efficacy of available antihypertensive agents used in pregnancy is lacking. OBJECTIVE: To compare treatment success with antihypertensives and categorize by route of administration. SEARCH STRATEGY: MEDLINE, Embase, PubMed, Web of Science, Scopus, CINAHL, and clinicaltrials.gov were searched without date restriction. DATA COLLECTION: Peer-reviewed randomized controlled trials (RCTs) comparing pharmacologic agents used to treat hypertension in parturients were included...
October 17, 2023: Pregnancy Hypertension
https://read.qxmd.com/read/37818947/primary-aldosteronism-2-0-an-update-for-clinicians-on-diagnosis-and-treatment
#25
JOURNAL ARTICLE
Stefan Pilz, Tomaz Kocjan, Verena Theiler-Schwetz, Christian Trummer
Primary aldosteronism (PA), characterized by inappropriately high concentrations of the adrenal derived hormone aldosterone, is the most common endocrine cause of arterial hypertension. Compared to essential hypertension, patients with PA have a significantly increased cardiovascular risk that cannot be fully reversed by common antihypertensive treatment because of blood pressure independent deleterious effects of aldosterone. The aldosterone to renin ratio (ARR), reflecting the degree of aldosterone excess, is the classic screening test for PA, but thresholds for an elevated ARR vary substantially and are arbitrary as there exists a wide disease continuum that spans from pre-clinical stages to overt PA...
October 11, 2023: Polish Archives of Internal Medicine
https://read.qxmd.com/read/37802822/-interpretation-and-review-of-clinical-practice-guidelines-for-management-of-hypertension-in-china-2020-edition-and-exploration-of-traditional-chinese-medicine-for-antihypertensive-treatment
#26
JOURNAL ARTICLE
Xiao-Ya Wang, Peng-Qian Wang, Xing-Jiang Xiong
Hypertension is the most important risk factor for cardiovascular disease-related deaths among urban and rural residents, and it has become a significant global public health issue. In October 2022, the Clinical Practice Guidelines for the Management of Hypertension in China(hereinafter referred to as the Practice Guidelines) were jointly released by the National Cardiovascular Center and other academic organizations. The Practice Guidelines sparked extensive discussions as they clearly lowered the diagnostic criteria for hypertension, raised the blood pressure targets for elderly patients, and proposed changes in the timing of early medication intervention...
September 2023: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/37727061/treatment-deferral-for-elevated-blood-pressure-at-a-dental-school-clinic
#27
JOURNAL ARTICLE
Sapna Nath, Tien Jiang, Jane Barrow, Lisa Simon
OBJECTIVES: Current guidelines by the American Dental Association (ADA) recommend deferral of elective dental care for elevated blood pressure. However, it is unknown how frequently this impacts dental treatment. The purpose of this study was to evaluate rates of asymptomatic hypertension and treatment deferral at a dental school clinic. METHODS: This was a retrospective study with data extracted from a chart review of all patients presenting for care at a dental school teaching practice...
September 19, 2023: Journal of Dental Education
https://read.qxmd.com/read/37668854/the-pivotal-role-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-blockers-in-hypertension-management-and-cardiovascular-and-renal-protection-a-critical-appraisal-and-comparison-of-international-guidelines
#28
REVIEW
Luis Antonio Alcocer, Alfonso Bryce, David De Padua Brasil, Joffre Lara, Javier Moreno Cortes, Daniel Quesada, Pablo Rodriguez
Arterial hypertension is the main preventable cause of premature mortality worldwide. Across Latin America, hypertension has an estimated prevalence of 25.5-52.5%, although many hypertensive patients remain untreated. Appropriate treatment, started early and continued for the remaining lifespan, significantly reduces the risk of complications and mortality. All international and most regional guidelines emphasize a central role for renin-angiotensin-aldosterone system inhibitors (RAASis) in antihypertensive treatment...
November 2023: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/37665450/cost-utility-analysis-of-valsartan-enalapril-and-candesartan-in-patients-with-heart-failure-in-iran
#29
JOURNAL ARTICLE
Ramin Ravangard, Farideh Sadat Jalali, Marjan Hajahmadi, Abdosaleh Jafari
BACKGROUND: Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each year, and the prevalence of heart failure is expected to increase by 25%. One of the preventive interventions is pharmacological interventions which can be used to reduce the complications of cardiovascular diseases such as heart failure. One of the most important pharmacological interventions in patients with heart failure is the use of antihypertensive drugs such as candesartan, enalapril, and valsartan...
September 4, 2023: Health Economics Review
https://read.qxmd.com/read/37641987/novel-invasive-methods-as-the-third-pillar-for-the-treatment-of-essential-uncontrolled-hypertension
#30
JOURNAL ARTICLE
Panagiotis-Anastasios Tsioufis, Panagiotis Theofilis, Panayotis K Vlachakis, Kyriakos Dimitriadis, Dimitris Tousoulis, Konstantinos Tsioufis
Pharmacologic therapies remain the treatment of choice for patients with essential hypertension, as endorsed by international guidelines. However, several cases warrant additional modalities, such as invasive antihypertensive therapeutics. The major target of these interventions is the modulation of the sympathetic nervous system, which is a common pathophysiologic mechanism in essential hypertension. In this narrative review, we elaborate on the role of invasive antihypertensive treatments with a focus on renal denervation, stressing their potential as well as the drawbacks that prevent their widespread implementation in everyday clinical practice...
August 28, 2023: Current Pharmaceutical Design
https://read.qxmd.com/read/37601158/hypertension-management-and-drug-related-problems-a-case-report-of-the-23-year-history-of-mr-jonas
#31
Indre Treciokiene, Jurate Peceliuniene, Bjorn Wettermark, Jolanta Gulbinovic, Katja Taxis
Arterial hypertension is a lifelong disease, which management is recognized as the most effective way to reduce cardiovascular mortality. Even though there is extensive evidence on the benefits of lifestyle modification and antihypertensive treatment, many patients with hypertension do not reach blood pressure targets. This paper aims to review the history of antihypertensive treatment of one patient and identify the drug related problems that occurred over the study period. In this case report, the patient's health record was studied, guidelines checked and a semi-structured interview conducted...
September 2023: Explor Res Clin Soc Pharm
https://read.qxmd.com/read/37594718/hypertension-treatment-in-frail-older-adults-a-systematic-review-and-appraisal-of-guidelines
#32
JOURNAL ARTICLE
Kaiyan Hu, Gang Zhou, Mengyao Jiang, Xiaohong Wei, Jing Yu, Li Liu, Zhe Wang, Liyuan Feng, Mei Wu, Tao Li, Bin Ma
BACKGROUND: Managing hypertension in frail older patients is challenging. Several institutions and organizations have published up-to-date hypertension guidelines suggesting frailty screening among older hypertensive patients, with new recommendations for blood pressure-lowering treatment among the frail population. However, the quality of current hypertension guidelines and the consistency of antihypertension treatment recommendations for frail older patients and their supporting evidence remain unknown...
October 2023: Drugs & Aging
https://read.qxmd.com/read/37582134/do-antihypertensive-drugs-combinations-in-single-pill-combination-improve-cardiovascular-outcomes
#33
REVIEW
Horacio A Carbajal, Martín R Salazar
Recommendations and guidelines propose to combine antihypertensive drugs to improve BP control, highlighting the advantages of single-pill combinations (SPCs) to improve treatment adherence. It is speculated that, compared with free-dose combinations (Free-DCs), SPC should achieve a reduction in cardiovascular (CV) events and mortality through better adherence and BP control. However, there is little information in this regard. For this reason, the objective of this review was to provide a descriptive analysis the differences in CV outcomes between SPCs antihypertensive drugs treatments vs...
2023: Medicina
https://read.qxmd.com/read/37546040/comparing-triple-combination-drug-therapy-and-traditional-monotherapy-for-better-survival-in-patients-with-high-risk-hypertension-a-systematic-review
#34
REVIEW
Mustafa Abrar Zaman, Nimra Awais, Travis Satnarine, Areeg Ahmed, Ayesha Haq, Deepkumar Patel, Sai Dheeraj Gutlapalli, Grethel N Hernandez, Kofi Seffah, Safeera Khan
High-risk hypertension patients are more susceptible to cardiovascular disease, stroke, and mortality. Monotherapy and triple combination drug therapy are two different approaches to treating hypertension. Monotherapy involves using a single medication to manage hypertension, whereas triple combination therapy involves the simultaneous use of three different antihypertensive medications from different drug classes. Making a fast switch from monotherapy to combination medication is one method to regulate blood pressure (BP) better...
July 2023: Curēus
https://read.qxmd.com/read/37544846/catheter-based-renal-artery-denervation-facts-and-expectations
#35
JOURNAL ARTICLE
Paolo Verdecchia, Claudio Cavallini, Rocco Sclafani, Andrea Santucci, Francesco Notaristefano, Gianluca Zingarini, Giovanni Andrea Colombo, Fabio Angeli
Catheter-based renal artery denervation (RAD) is entering a new era. After the disappointing results of SYMPLICITY-HTN 3 trial in year 2014, several technical and methodological advancements led to execution of important SHAM-controlled randomized trials with promising results. Now, the 2023 ESH Guidelines give RAD a class of recommendation II with a Level of Evidence B. Currently, catheter-based RAD has two main areas of application: (a) Hypertensive patients who are still untreated, in whom RAD is a sort of a first-line treatment; (b) Difficult-to-control or true resistant hypertensive patients...
August 4, 2023: European Journal of Internal Medicine
https://read.qxmd.com/read/37512012/covid-19-and-the-use-of-angiotensin-ii-receptor-blockers-in-older-chronic-hypertensive-patients-systematic-review-and-meta-analysis
#36
REVIEW
Miguel Quesada-Caballero, Ana Carmona-García, Sara Chami-Peña, Luis Albendín-García, Cristina Membrive-Jiménez, José L Romero-Béjar, Guillermo A Cañadas-De la Fuente
Angiotensin II-converting enzyme inhibitors (ACEIs) and selective angiotensin II receptor antagonists (ARAIIs) are widely used antihypertensive agents. Their use has generated controversy due to their possible influence on the health status of chronic patients infected with COVID-19. The objective of this work is to analyze the influence of COVID-19 on chronic hypertensive patients treated with ACEI and ARAII inhibitors. A systematic review and meta-analysis in the databases Pubmed, Pro-Quest and Scopus were carried out...
June 26, 2023: Medicina
https://read.qxmd.com/read/37498450/addressing-cardiovascular-risk-across-the-arc-of-a-woman-s-life-sex-specific-prevention-and-treatment
#37
REVIEW
Dhiran Verghese, Laura Muller, Shona Velamakanni
PURPOSE OF REVIEW: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in women in the United States of America. Despite this, women are underdiagnosed, less often receive preventive care, and are undertreated for CVD compared to men. There has been an increase in sex-specific risk factors and treatments over the past decade; however, sex-specific recommendations have not been included in the guidelines. We aim to highlight recent evidence behind the differential effect of traditional risk factors and underscore sex-specific risk factors with an intention to promote awareness, improve risk stratification, and early implementation of appropriate preventive therapies in women...
July 27, 2023: Current Cardiology Reports
https://read.qxmd.com/read/37491419/exercise-training-and-resting-blood-pressure-a-large-scale-pairwise-and-network-meta-analysis-of-randomised-controlled-trials
#38
REVIEW
Jamie J Edwards, Algis H P Deenmamode, Megan Griffiths, Oliver Arnold, Nicola J Cooper, Jonathan D Wiles, Jamie M O'Driscoll
OBJECTIVE: To perform a large-scale pairwise and network meta-analysis on the effects of all relevant exercise training modes on resting blood pressure to establish optimal antihypertensive exercise prescription practices. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: PubMed (Medline), the Cochrane library and Web of Science were systematically searched. ELIGIBILITY CRITERIA: Randomised controlled trials published between 1990 and February 2023...
October 2023: British Journal of Sports Medicine
https://read.qxmd.com/read/37463810/clinical-course-and-outcomes-in-adults-with-co-occurring-hypertrophic-cardiomyopathy-and-hypertension-a-scoping-review-protocol
#39
JOURNAL ARTICLE
Milla Arabadjian, Barnaby Nicolas, Sophie Montgomery, Mitchell Pleasure, Maxine Collins, Maria Reuter, Daniele Massera, Daichi Shimbo, Mark Sherrid
INTRODUCTION: Hypertension affects 40%-60% of adults with hypertrophic cardiomyopathy (HCM), the most common inherited cardiac condition. It can be a diagnostic confounder for HCM, contributing to delayed diagnosis. Clinically, treatment of co-occurring hypertension and HCM poses challenges as first-line and second-line antihypertensive medications are often contraindicated in HCM. The clinical course in adults with hypertension and HCM is also not well understood, and studies examining patient outcomes in this population are equivocal...
July 18, 2023: BMJ Open
https://read.qxmd.com/read/37443261/arterial-hypertension-clinical-trials-update-2023
#40
REVIEW
Felix Götzinger, Michael Kunz, Lucas Lauder, Michael Böhm, Felix Mahfoud
Arterial hypertension is associated with increased morbidity and mortality and research in the field is highly dynamic. This summary reviews the most important clinical trials published in 2022 and early 2023. Findings on new pharmacological approaches to treat resistant hypertension are presented and new knowledge about the optimal timing of the antihypertensive medication intake is discussed. It is focused on optimal blood pressure treatment targets and the problem of treatment and guideline inertia is acknowledged...
September 2023: Hypertension Research: Official Journal of the Japanese Society of Hypertension
keyword
keyword
8816
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.